신경자극 기기 시장 : 제품, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Neurostimulation Device Market was valued at USD 9.65 billion in 2023, expected to reach USD 10.72 billion in 2024, and is projected to grow at a CAGR of 11.18%, to USD 20.28 billion by 2030.

Neurostimulation devices are medical technologies used to deliver electrical stimulation to specific parts of the nervous system for therapeutic purposes, such as pain management, rehabilitation, and various neurological disorders. The necessity for neurostimulation devices arises from their ability to provide non-pharmacological interventions for conditions like chronic pain, epilepsy, Parkinson's disease, and depression, driving significant demand within the healthcare sector. These devices are utilized in hospitals, clinics, and home-care settings, with applications expanding across diverse areas such as deep brain stimulation, spinal cord stimulation, and transcranial magnetic stimulation. Key factors influencing market growth include the aging population, increasing prevalence of neurological disorders, advancements in technology, and growing awareness about alternative therapies. Recent innovations, like minimally invasive procedures and enhanced battery life, provide potential opportunities for market expansion. Recommendations to seize these opportunities include investing in R&D to enhance device efficacy and patient customization, as well as collaborating with healthcare providers to increase adoption. However, market growth is challenged by factors like high device costs, stringent regulatory requirements, and potential side effects or complications associated with use. Additionally, reimbursement policies in various regions can limit accessibility to these devices. Despite these challenges, the market presents opportunities for innovation, particularly in developing wireless neurostimulation devices and integrating AI for personalized treatment plans, which can further drive adoption and acceptance. Furthermore, the potential innovation lies in enhancing user-interface technologies to improve patient and provider interactions with the device. The nature of the neurostimulation device market is dynamic, with significant investments in R&D fostering a competitive landscape. Firms that can navigate regulatory landscapes, reduce costs, and develop patient-friendly, effective solutions stand to gain a competitive edge, cater to unmet needs, and achieve significant business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Neurostimulation Device Market

The Neurostimulation Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of neurological disorders
  • Rising cases of depression and chronic pain
  • Favorable reimbursement scenario and government awareness programs
• Market Restraints
  • High cost of neurostimulation devices
  • Presence of alternative therapeutic procedures
• Market Opportunities
  • Investment for neurological R&D for technologically advanced products
  • Development of closed-loop neuromodulation
• Market Challenges
  • Dearth of trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Neurostimulation Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Neurostimulation Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Neurostimulation Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Neurostimulation Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Neurostimulation Device Market

A detailed market share analysis in the Neurostimulation Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Neurostimulation Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Neurostimulation Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Neurostimulation Device Market

A strategic analysis of the Neurostimulation Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Neurostimulation Device Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Aleva Neurotherapeutics SA, Boston Scientific Corporation, Medtronic, Inc., Neuropace, Inc., Neurosigma, Inc., St. Jude Medical Inc., and Synapse Biomedical, Inc..

Market Segmentation & Coverage

This research report categorizes the Neurostimulation Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Deep Brain Stimulation Devices, Gastric Electric Stimulation Devices, Sacral Nerve Stimulation Devices, Spinal Cord Stimulation Devices, and Vagus Nerve Stimulation Devices.
• Based on Application, market is studied across Alzheimer's, Chronic Pain Management, Epilepsy, Ischemia, and Parkinson's Disease.
• Based on End User, market is studied across Hospitals and Scientific Research Laboratories.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of neurological disorders
    • 5.1.1.2. Rising cases of depression and chronic pain
    • 5.1.1.3. Favorable reimbursement scenario and government awareness programs
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of neurostimulation devices
    • 5.1.2.2. Presence of alternative therapeutic procedures
  • 5.1.3. Opportunities
    • 5.1.3.1. Investment for neurological R&D for technologically advanced products
    • 5.1.3.2. Development of closed-loop neuromodulation
  • 5.1.4. Challenges
    • 5.1.4.1. Dearth of trained professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Neurostimulation Device Market, by Product

• 6.1. Introduction
• 6.2. Deep Brain Stimulation Devices
• 6.3. Gastric Electric Stimulation Devices
• 6.4. Sacral Nerve Stimulation Devices
• 6.5. Spinal Cord Stimulation Devices
• 6.6. Vagus Nerve Stimulation Devices

7. Neurostimulation Device Market, by Application

• 7.1. Introduction
• 7.2. Alzheimer's
• 7.3. Chronic Pain Management
• 7.4. Epilepsy
• 7.5. Ischemia
• 7.6. Parkinson's Disease

8. Neurostimulation Device Market, by End User

• 8.1. Introduction
• 8.2. Hospitals
• 8.3. Scientific Research Laboratories

9. Americas Neurostimulation Device Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Neurostimulation Device Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Neurostimulation Device Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Aleva Neurotherapeutics SA
• 3. Boston Scientific Corporation
• 4. Medtronic, Inc.
• 5. Neuropace, Inc.
• 6. Neurosigma, Inc.
• 7. St. Jude Medical Inc.
• 8. Synapse Biomedical, Inc.